United Healthcare Services Inc v. Rossel

District Court, N.D. Texas·Decided May 16, 2025·No. 3:21-cv-01547·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS DALLAS DIVISION

UNITED HEALTHCARE § SERVICES, INC. and UNITED § HEALTHCARE COMPANY, § § Plaintiffs, § § v. § Case No. 3:21-cv-1547-L-BT § JEREMY ROSSEL, AMIR § MORTAZAVI, CARY ROSSEL, § ARVIN ZEINALI, YAN NAROSOV, § and SEMYON NAROSOV, § § Defendants. §

FINDINGS, CONCLUSIONS, AND RECOMMENDATION OF THE UNITED STATES MAGISTRATE JUDGE

This matter has been referred to the undersigned for pretrial management. ECF No. 672. Before the Court is Plaintiffs’ Renewed Motion for Default Judgment Against Defendant Semyon Narosov, ECF No. 766. For the reasons stated below, the District Judge should GRANT in part the motion. Background While the parties are familiar with the extensive factual and procedural history of this litigation, the Court recounts the following background facts to provide context for its ruling: In January 2017, Plaintiffs sued Next Health LLC and several affiliated entities including laboratories (collectively, “Next Health”) for a variety of claims related to an alleged multi-million-dollar healthcare fraud scheme. See United Healthcare Services, Inc., et al. v. Next Health, LLC, et al., 3:17-cv-00243 (N.D. Tex.) (hereinafter, the “Next Health case”), Compl., ECF No. 1. Succinctly stated, Plaintiffs alleged that Next Health defrauded them of over $100 million by

submitting false and misleading claims seeking payment for lab tests and prescription medications, which Next Health accomplished through a network of shell companies and marketers that funneled kickbacks to doctor referral sources. Id., passim. Plaintiffs also alleged that Andrew Hillman and Semyon Narosov controlled Next Health, and that both had been indicted for their roles in

laundering money derived from healthcare fraud. Id. ¶¶ 3, 7, 73. In 2018, Andrew Hillman and Semyon Narosov pleaded guilty to using Next Health to launder money derived from healthcare fraud. See generally Plea Agreement, U.S. v. Semyon Narosov, Andrew Hillman, No. 3:18-CR-0475-JJZ, 2018 WL 11193541, ECF Nos. 8, 9 (N.D. Tex. Sept. 24, 2018). More specifically, Semyon Narosov admitted he had fraudulently caused claims to be submitted for

prescriptions that were induced by kickbacks, prescriptions that were medically unnecessary, prescriptions filled with misbranded and non-FDA-approved drugs, and prescriptions for which no copays had been collected. See Pls.’ App. in Support of Renewed Mot. Default J., ECF No. 766-1 at 4-10 (Factual Resume). In 2019, Plaintiffs filed their First Amended Complaint in the Next Health

case, adding numerous individual defendants, including Mike Austin, Nick Austin, Josh Daniel, Josh Ihde, Cary Rossel, Jeremy Rossel, Yan Narosov, Arvin Zeinali and Amir Mortazavi (the “Executive Defendants”), as well as Andrew Hillman and Semyon Narosov, multiple pharmacies, and Pioneer Laboratories, LLC. Next Health, 3:17-cv-00243, First Am. Compl. ¶¶ 29-30, 31-33, 35-40, 43, ECF No. 348. Semyon Narosov never answered or otherwise respond to the First Amended

Complaint. After the clerk entered default, see ECF No. 484, Plaintiffs filed a motion for default judgment. See ECF No. 499. Subsequently, upon Semyon Narosov’s motion, the Court set aside the default and denied Plaintiffs’ motion for default judgment. See Order, ECF No. 556. In 2021, Plaintiffs filed their Second Amended Complaint in the Next Health

case, in which they alleged that the Executive Defendants and Semyon Narosov owned and operated Next Health and affiliated entities and used them to engineer and execute a complex scheme to defraud health plans by submitting claims with false, misleading, and/or incomplete information to Plaintiffs, which were intended to trick Plaintiffs into paying exorbitant amounts for laboratory testing services and pharmaceutical products. Next Health, 3:17-cv-00243, Sec. Am.

Compl., passim, ECF No. 584. With respect to the Executive Defendants and Semyon Narosov, Plaintiffs asserted claims for fraud and fraudulent nondisclosure (Count 1); conspiracy to commit fraud (Count 2); fraudulent transfers (Count 11); and violations of the Racketeer Influenced and Corrupt Organizations Act (RICO), 18 U.S.C. § 1962(c) (Count 12). See Second Am. Compl., ECF No. 584.

On April 16, 2021, rather than file an answer or otherwise respond to the Second Amended Complaint, Semyon Narosov filed a “[n]otice that he will not contest liability and will only contest damages.” See Notice, ECF No. 608. In the Notice, he explained that his decision to not defend was based on three circumstances: (1) his conviction and the terms of his plea agreement, including the sworn statements he made in connection with his plea agreement, effectively

precluded him from contesting liability; (2) any statements he would make in the future during this case might be used against him in subsequent criminal prosecutions; and (3) he had limited financial resources to pay for a defense. See id. Semyon Narosov never filed any pleading in response to the Second Amended Complaint.

In July 2021, presiding United States District Judge Ada Brown severed Plaintiffs’ claims against the Executive Defendants and Semyon Narosov from the Next Health case, giving rise to the instant lawsuit. Next Health, 3:17-cv-00243, Order, ECF No. 613. In May 2022, Judge Brown recused herself from the Next Health case, as well as this severed case against the Executive Defendants and Semyon Narosov.

The Next Health case was reassigned to United States District Judge Brantley Starr. See Next Health, No. 3:17-cv-00243, ECF No. 683.1 The severed case against the Executive Defendants and Semyon Narosov was reassigned to United States District Judge Sam A. Lindsay. See ECF No. 621.2

1 The Next Health case resolved with several summary and/or default judgments as to the remaining defendants. See Next Health, No. 3:17-cv-00243, ECF No. 750. 2 The operative pleadings in the Next Health case became the operative pleadings in this case. On March 20, 2023, the Court granted Semyon Narosov’s attorney’s motion to withdraw. See Order, ECF No. 633. On October 17, 2024, at Plaintiffs’ request, the Clerk entered default against Semyon Narosov. See Entry of Default, ECF No.

760. On November 6, 2024, Plaintiffs filed their renewed motion requesting that the Court enter default judgment against Semyon Narosov under Federal Rule of Civil Procedure 55(b)(2). See Pls.’ Renewed Mot. Default J., ECF No. 766. Legal Standards Federal Rule of Civil Procedure 55 governs the entry of default and default

judgment. There are three stages to entry of default judgment. First, a default occurs “when a defendant has failed to plead or otherwise respond to the complaint within the time required by the Federal Rules.” New York Life Ins. Co. v. Brown, 84 F.3d 137, 141 (5th Cir. 1996); see also Fed. R. Civ. P. 55(a) (noting default occurs where the defendant “has failed to plead or otherwise defend” against the complaint). Second, the Clerk may enter a defendant’s default if it is “established

by affidavit or otherwise.” Brown, 84 F.3d at 141 (citing Fed. R. Civ. P. 55(a)).

Free access — add to your briefcase to read the full text and ask questions with AI

United Healthcare Services Inc v. Rossel, (N.D. Tex. 2025).

United Healthcare Services Inc v. Rossel (United Healthcare Services Inc v. Rossel) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related